Anixa Biosciences shareholders re-elect four directors, approve executive pay
At its annual meeting on March 10, 2026, Anixa Biosciences stockholders re-elected four directors, approved executive compensation on a non-binding advisory basis, and ratified Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending October 31, 2026. The company also filed a presentation used by management at the meeting as Exhibit 99.1, which may be used in future investor meetings.
Key points
- Shares present or represented by proxy: 20,805,324 of 33,379,505 shares entitled to vote
- Executive compensation approved: 6,025,247 votes for, 2,973,752 against, 137,032 abstentions
- Dr. Amit Kumar re-elected with 8,917,813 votes for and 218,238 withheld; the other three nominees received between 7,176,739 and 7,425,900 votes for
- Auditor ratification: 20,426,524 votes for, 191,432 against, 187,368 abstaining
The filing
Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 11, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.